Logo

NeoGenomics: Vishal Sikri

May 09, 2022

NeoGenomics announced that Vishal Sikri will take over as president and chief commercial officer of its subsidiary Inivata on May 23. Sikri was most recently president of oncology at Invitae and previously served as SVP of oncology product strategy and management at the company. Before that, he was US general manager at Biocartis and VP of commercial operations at liquid biopsy company Sysmex Inostics. 

NeoGenomics also announced the departure of Gina Wallar, the firm's president of the pharma services division, effective May 27. Jennifer Rose, VP of pharma sales and project management operations, will take over in the interim.

Breaking News
The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.